Facial fat grafting: structural fat, microfat, and nanofat are not the same product

Structural fat, microfat, and nanofat are processing descriptions, not three interchangeable injectables. Structural fat and microfat preserve parcels intended to provide volume with surviving adipocytes; nanofat is mechanically processed into a finer emulsion with little or no intact adipocyte architecture and is studied mainly for skin-quality effects. None of those names alone specifies harvest site, processing, particle distribution, viable-cell content, injection plane, dose, sterility, evidence, or expected retention.²⁵

Facial fat grafting rose 39% in ASPS’s newly released 2025 statistics.¹ That attention makes precise product language more important, not less.

Start with the job: volume, transition, or skin quality

“Regenerative facial” is not a measurable job. Define whether the goal is cheek projection, temple transition, lid-cheek contour, scar appearance, texture, pigment, fine lines, or another bounded feature. Adding volume and changing skin appearance are different hypotheses and need different photographs and outcome measures.

The preparation name does not standardize the product

Published protocols vary in donor site, infiltration, aspiration pressure, cannula, centrifugation, gravity separation, washing, filtration, emulsification passes, mesh size, exposure to air, additives, time outside the body, and final delivery device.² Two clinics can both say “nanofat” while preparing materially different fractions.

Ask for a one-page preparation record that includes:

• donor site and harvest technique;
• all solutions and additives;
• closed or open processing steps;
• centrifuge force and time, not “a gentle spin”;
• connector, filter or mesh sequence;
• passes used to emulsify;
• final syringe volume and appearance;
• time from harvest to placement;
• cannula or needle dimensions; and
• which preparation entered each facial region.

This is not a request for a proprietary recipe. It is the minimum record needed to know what was implanted.

Nanofat is not simply very small filler

Classic nanofat processing disrupts mature adipocytes. The resulting material is not expected to behave as a durable parcel-volume graft in the same way as intact fat. Reviews describe studies focused on texture, photoaging, scars, pigment, or other skin-quality endpoints, but protocols and outcome measures vary and many studies are small or uncontrolled.²⁵

The word “stem cell” is especially easy to overread. A processed autologous fraction can contain stromal and vascular components; that fact alone does not specify a standardized cell dose or prove a clinical regenerative effect.²⁵ Ask what was measured in the cited study: histology, a rating scale, instrument reading, patient satisfaction, photographs, or durable clinical change.

If a clinic adds PRP, PRF, exosomes, peptides, laser, microneedling, or another product, the evidence and regulatory story change again. The PRP-versus-PRF guide shows why a blood-derived label also requires a preparation record.

Retention is a range, not a promise

Objectively measured facial fat-graft retention varies widely across published studies, and reported estimates depend partly on follow-up and the measurement method. Patient, anatomic, and technique factors may also matter, but they do not produce a guaranteed individual percentage.⁴ Swelling is not retained graft volume.

Ask how the practice separates:

1. immediate injected volume;
2. early swelling and bruising;
3. intermediate settling;
4. measured longer-term contour; and
5. any later weight-related change.

Standardized photographs should keep lighting, lens, distance, expression, head position, and timing consistent. Three-dimensional imaging can add information but does not eliminate measurement error or prove that one processing label caused the result.

A face map is more useful than a syringe count

The consultation should identify each target compartment and the tissue layer proposed. Temple, forehead, brow, upper eyelid, lower eyelid, cheek, nasolabial region, lips, chin, jawline, and scars have different anatomy and risk. A total volume without region and plane cannot be compared across quotes.

The map should state:

• preparation assigned to each target;
• planned volume range and injection instrument;
• vascular and nerve anatomy considered;
• prior filler, threads, surgery, trauma, infection, dental work, or energy treatment;
• whether ultrasound or other imaging changes the plan; and
• what finding causes a region to be skipped.

The existing fat-versus-filler comparison addresses donor-site surgery, adjustability, material, reversibility, and maintenance. This article begins after autologous fat is already under discussion and asks what kind of fat preparation is actually proposed.

Harvest and recipient sites create two recovery records

Facial fat grafting includes a donor procedure. The plan should name donor area, incision sites, liposuction method, garment or wound care, activity effects, contour risk, and who manages donor-site problems. A small facial volume can still require a meaningful harvest process.

The recipient record should cover bruising, swelling, asymmetry, infection, nodules, oil cysts, fat necrosis, contour irregularity, under- or overcorrection, vascular injury, nerve symptoms, and region-specific eye or airway concerns.³ Rare does not mean irrelevant; the response plan should identify urgent contacts and destinations.

Do not use “your own natural tissue” as a synonym for reversible or risk-free. Autologous origin changes some tradeoffs; it does not erase surgery, variability, or anatomy.

Evidence must match the exact preparation and endpoint

When a clinic cites a study, compare:

• structural fat, microfat, nanofat, stromal vascular fraction, or another preparation;
• harvest and processing protocol;
• injection route, depth, region, and volume;
• simultaneous surgery or devices;
• comparator and randomization;
• patient number and follow-up;
• blinded versus unblinded assessment;
• volume, skin, scar, pigment, satisfaction, or histologic endpoint; and
• adverse-event definitions.

A paper on nanofat for acne scars cannot prove predictable temple volume. A structural graft series cannot validate claims that nanofat “reverses aging at the cellular level.”

1. Name the job Separate structural volume, contour transition, scar or skin-quality goals and give each a measurable endpoint.
2. Define the product Record harvest, processing, final composition description, timing, volume, instrument and additives.
3. Map the placement Assign preparation, plane, volume range, instrument and stop criteria to every facial region.
4. Match the evidence Use studies with the same preparation, route, target, comparator, outcomes and follow-up.
5. Plan both sites Price and prepare for donor and facial recovery, follow-up, asymmetry review and complication response.

Ask for preparation, placement, and purpose in one sentence

The decisive question is: “What exactly will be harvested and processed into structural fat, microfat, or nanofat; where will each fraction be placed; and which measured endpoint supports that choice?” The smallest-sounding particle is not automatically the most advanced treatment.